Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer
2014
Activation of the insulin-like growth factor 1 receptor may underlie clinical resistance to inhibition of the anaplastic lymphoma receptor kinase in lung cancer.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
32
References
192
Citations
NaN
KQI